Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus.

Stocchi F, Antonini A, Berg D, Bergmans B, Jost W, Katzenschlager R, Kulisevsky J, Odin P, Valldeoriola F, Ray Chaudhuri K

Open source

DOI
10.1038/s41531-022-00277-z
Published
2022 Feb 21
Container
NPJ Parkinson's disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41531-022-00277-z,
  title = {Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus.},
  author = {Stocchi F and Antonini A and Berg D and Bergmans B and Jost W and Katzenschlager R and Kulisevsky J and Odin P and Valldeoriola F and Ray Chaudhuri K},
  year = {2022},
  journal = {NPJ Parkinson's disease},
  doi = {10.1038/s41531-022-00277-z},
  url = {https://doi.org/10.1038/s41531-022-00277-z}
}

RIS

TY  - JOUR
TI  - Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus.
AU  - Stocchi F
AU  - Antonini A
AU  - Berg D
AU  - Bergmans B
AU  - Jost W
AU  - Katzenschlager R
AU  - Kulisevsky J
AU  - Odin P
AU  - Valldeoriola F
AU  - Ray Chaudhuri K
PY  - 2022
JO  - NPJ Parkinson's disease
DO  - 10.1038/s41531-022-00277-z
UR  - https://doi.org/10.1038/s41531-022-00277-z
ER  - 

APA

F, S., A, A., D, B., B, B., W, J., R, K., J, K., P, O., F, V., & K, R. C. (2022). Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus.. NPJ Parkinson's disease. https://doi.org/10.1038/s41531-022-00277-z

Source records